單孔腹腔鏡手術器械市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

2024 年全球單孔腹腔鏡手術器械市場價值為 8.34 億美元，預計到 2034 年將以 8.6% 的複合年成長率成長至 19 億美元。

市場成長主要受肥胖症、大腸直腸疾病和婦科疾病發病率上升、患者對微創手術方式的偏好日益成長以及門診手術數量不斷增加等因素驅動。單孔腹腔鏡手術（SPLS）設備標誌著微創技術的重大進步，它使外科醫生能夠透過一個通常位於臍部附近的小切口完成複雜的手術，從而顯著減少疤痕、組織損傷和恢復時間。這些設備迅速被尋求疼痛更輕、住院時間更短、恢復更快、美容效果更好的手術方式的醫護人員和患者所接受。與傳統開放性手術相比，由於切口較小，單孔腹腔鏡手術併發症較少，感染風險較低。手術技術的不斷發展和單孔平台的人體工學改進持續提升手術的精準度、控制性和效率，從而推動了全球醫院和門診中心的強勁需求。

2024年，腹腔鏡器械市佔率達42.2%。其成長主要源自於對專用精密器械的需求，這些器械能夠支援透過單一切口進行複雜的操作，尤其是在解剖結構受限的手術區域。套管針、剪刀、分離器、抓鉗和持針器等器械在確保手術過程中的精準控制和靈活性方面發揮著至關重要的作用。這些器械幫助外科醫生剋服了單孔手術中常見的器械擁擠和三角定位受限等挑戰。符合人體工學和可彎曲器械設計的進步進一步提升了手術效果，並推動了該細分市場的擴張。

2024年，一般外科手術市場規模達3.604億美元。其市場主導地位源自於大量適合單孔入路的手術，例如闌尾切除術、疝氣修補術和膽囊切除術。隨著單孔入路技術在住院和門診機構的接受度不斷提高，該市場持續受益。由於單孔入路手術恢復時間短、疤痕小、整體臨床療效好，患者和醫護人員越來越傾向選擇單孔入路手術。普通外科手術病例數量的成長以及手術入路系統的不斷進步，進一步鞏固了該領域對單孔入路手術器械的強勁需求。

2024年，美國單孔腹腔鏡手術器械市場規模預計將達3.579億美元。美國在全球採用先進的單孔腹腔鏡系統方面處於領先地位，這主要得益於其優惠的醫保政策、高素質的外科醫生隊伍以及對醫療創新持續不斷的投入。該地區大力支持外科培訓、開發數位化手術平台以及整合基於模擬的學習，所有這些因素都推動了單孔腹腔鏡手術（SPLS）技術在不同專科領域的廣泛應用。

全球單孔腹腔鏡手術器械市場的主要參與者包括強生、Applied Medical、貝朗、奧林巴斯、美敦力、史多斯、優尼邁、康基、CITEC、LOOKMED、GYTR-VII 和 Hospiinz。為了鞏固其在單孔腹腔鏡手術器材產業的地位，領導企業正致力於產品創新、建立合作夥伴關係和進行策略性收購，以擴大其全球影響力。許多企業正大力投資研發，以設計先進的手術入路端口、多功能器械平台和靈活的腹腔鏡工具，從而提高外科醫生的舒適度和手術效率。此外，各公司也正在加強分銷網路，並與醫院合作，以加速臨床應用。同時，他們也透過最佳化生產流程和在地化生產來提高產品的價格競爭力，並擴大培訓項目，以提高外科醫生的技能水平，確保各地區市場的持續成長。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

• 產業生態系分析
• 產業影響因素
  • 成長促進因素
    • 肥胖、大腸直腸疾病和婦科疾病的盛行率不斷上升
    • 技術進步
    • 人們對微創手術的偏好日益成長
    • 門診手術量激增
  • 產業陷阱與挑戰
    • 腹腔鏡設備成本高昂
    • 嚴格的政府法規
  • 市場機遇
    • 醫療基礎設施擴建
    • 開發靈活、符合人體工學且可重複使用的儀器
• 成長潛力分析
• 監管環境
  • 北美洲
  • 歐洲
  • 亞太地區
• 2024年定價分析
• 價值鏈分析
• 未來市場趨勢
• 報銷方案
• 技術格局
  • 目前技術
  • 新興技術
• 差距分析
• 波特的分析
• PESTEL 分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
  • 北美洲
  • 歐洲
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 合作夥伴關係與合作
  • 新產品發布
  • 擴張計劃

第5章：市場估算與預測：依產品類型分類，2021-2034年

• 主要趨勢
• 存取裝置
• 腹腔鏡器械

第6章：市場估算與預測：依應用領域分類，2021-2034年

• 主要趨勢
• 一般外科
• 婦科手術
• 泌尿外科手術
• 減重手術
• 其他應用

第7章：市場估算與預測：依最終用途分類，2021-2034年

• 主要趨勢
• 醫院
• 門診手術中心
• 其他最終用途

第8章：市場估算與預測：依地區分類，2021-2034年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Applied Medical
• B. Braun
• CITEC
• GYTR-VII
• Hospiinz
• Johnson & Johnson
• KANGJI
• LOOKMED
• Medtronic
• OLYMPUS
• STORZ
• UNIMAX

The Global Single-Port Laparoscopic Surgery Devices Market was valued at USD 834 million in 2024 and is estimated to grow at a CAGR of 8.6% to reach USD 1.9 Billion by 2034.

Market growth is driven by the rising incidence of obesity, colorectal disorders, and gynecological diseases, combined with the growing patient preference for minimally invasive surgical approaches and the increasing number of outpatient procedures. Single-port laparoscopic surgery (SPLS) devices mark a major step forward in minimally invasive techniques, allowing surgeons to perform complex operations through one small incision, typically near the umbilicus, which significantly reduces scarring, tissue trauma, and recovery time. These devices have gained rapid adoption among healthcare professionals and patients seeking procedures with reduced pain, shorter hospital stays, quicker recovery, and better cosmetic results. Compared with traditional open surgeries, single-port laparoscopy offers fewer complications and a lower infection risk due to smaller incisions. The ongoing evolution of surgical technology and ergonomic improvements in single-port platforms continue to enhance precision, control, and procedural efficiency, fueling strong demand in hospitals and ambulatory centers worldwide.

The laparoscopic instruments segment held a 42.2% share in 2024. Its growth is primarily driven by the need for specialized precision tools that support intricate movements through a single incision, particularly in anatomically restricted surgical areas. Instruments such as trocars, scissors, dissectors, graspers, and needle holders play a critical role in ensuring precise control and dexterity during procedures. These devices help surgeons overcome common challenges associated with instrument crowding and limited triangulation, which are typical in single-port techniques. The advancement of ergonomic and articulating instrument designs is further improving surgical performance and driving the segment's expansion.

The general surgery segment generated USD 360.4 million in 2024. Its dominance stems from the high number of procedures suitable for single-port access, including appendectomy, hernia repair, and cholecystectomy. The segment continues to benefit from growing acceptance of single-port methods across both inpatient and outpatient facilities. Patients and providers are increasingly opting for SPLS due to its shorter recovery times, reduced scarring, and better overall clinical outcomes. The rising number of general surgical cases and continuous advancements in surgical access systems further reinforce the strong demand for SPLS devices in this segment.

U.S. Single-Port Laparoscopic Surgery Devices Market generated USD 357.9 million in 2024. The U.S. leads globally in adopting advanced single-port laparoscopic systems, driven by favorable reimbursement policies, the presence of a highly skilled surgical workforce, and consistent investments in healthcare innovation. The region benefits from strong support for surgical training, development of digital surgical platforms, and the integration of simulation-based learning, all of which are propelling the widespread implementation of SPLS technologies across different specialties.

Prominent companies active in the Global Single-Port Laparoscopic Surgery Devices Market include Johnson & Johnson, Applied Medical, B. Braun, Olympus, Medtronic, STORZ, UNIMAX, KANGJI, CITEC, LOOKMED, GYTR-VII, and Hospiinz. To reinforce their position in the single-port laparoscopic surgery devices industry, leading companies are focusing on product innovation, partnerships, and strategic acquisitions to expand their global reach. Many are investing heavily in research and development to design advanced access ports, multi-instrument platforms, and flexible laparoscopic tools that enhance surgeon comfort and efficiency. Firms are also strengthening distribution networks and entering collaborations with hospitals to accelerate clinical adoption. Additionally, they are emphasizing affordability through manufacturing optimization and local production, while expanding their training programs to increase surgeon proficiency and ensure consistent market growth across regions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Application trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of obesity, colorectal diseases, and gynecological conditions
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Rising preference for minimally invasive surgery
    • 3.2.1.4 Surge in outpatient surgeries
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of laparoscopic devices
    • 3.2.2.2 Stringent government regulations
  • 3.2.3 Market opportunities
    • 3.2.3.1 Healthcare infrastructure expansion
    • 3.2.3.2 Development of flexible, ergonomic, and reusable instruments
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Pricing analysis, 2024
• 3.6 Value chain analysis
• 3.7 Future market trends
• 3.8 Reimbursement scenario
• 3.9 Technology landscape
  • 3.9.1 Current technologies
  • 3.9.2 Emerging technologies
• 3.10 Gap analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 North America
  • 4.3.2 Europe
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Access devices
• 5.3 Laparoscopic instruments

Chapter 6 Market Estimates and Forecast, By Applications, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 General surgery
• 6.3 Gynecological surgery
• 6.4 Urological surgery
• 6.5 Bariatric surgery
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgery centers
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Applied Medical
• 9.2 B. Braun
• 9.3 CITEC
• 9.4 GYTR-VII
• 9.5 Hospiinz
• 9.6 Johnson & Johnson
• 9.7 KANGJI
• 9.8 LOOKMED
• 9.9 Medtronic
• 9.10 OLYMPUS
• 9.11 STORZ
• 9.12 UNIMAX